Is hyperbaric oxygen therapy safe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Hyperbaric Oxygen Safe?

Yes, hyperbaric oxygen therapy (HBOT) is safe when administered according to appropriate therapeutic protocols, with adverse events occurring in less than 1% of treatments and serious complications being extremely rare.

Safety Profile Based on Large-Scale Data

The most comprehensive safety data comes from analysis of 1.5 million hyperbaric treatments administered between 2012-2015, which demonstrated that only 0.68% of treatments were associated with any adverse event 1. This represents one of the largest safety analyses in HBOT literature and provides robust evidence for the therapy's safety profile.

Most Common Adverse Events (Mild and Manageable)

The adverse events that do occur are typically minor and easily managed:

  • Otic/sinus barotrauma - Most frequent complication (8.7% in elderly patients 2)
  • Confinement anxiety - Common but manageable with supportive care
  • Middle ear barotrauma - Preventable with proper equalization techniques

Rare but Serious Complications

Medically severe events are exceptionally uncommon:

  • Oxygen toxicity: Fewer than 0.05 instances per 1,000 treatments 1
  • Seizures: Rare, typically related to CNS oxygen toxicity, reversible without permanent sequelae 3
  • Pneumothorax: Only 1 confirmed case in 1.5 million treatments 1

Safety in Special Populations

Pregnant Women

HBOT has been administered safely to pregnant women 4, though no prospective efficacy studies exist. The therapy is used when fetal distress or death from conditions like carbon monoxide poisoning pose greater risk than the treatment itself.

Elderly Patients (≥75 Years)

Recent data from 1,799 sessions in patients aged 75+ showed a 20.3% side effect rate, comparable to younger populations 2. Most events were minor barotrauma or anxiety, with no life-threatening complications when strict pre-treatment evaluations were performed.

Critically Ill Patients

In COVID-19 patients with moderate-to-severe ARDS, HBOT at 2.4 ATA showed no statistically significant difference in adverse events compared to controls 5. Hypoxia was the most common event reported, but this was related to underlying disease rather than the therapy itself.

Thoracic Trauma Patients

A 2025 study of 25 patients with blunt thoracic trauma (including crush injuries) showed HBOT can be safely administered when individualized risk assessment is performed 3. While 20% developed respiratory or cardiac symptoms during treatment, most were minor and manageable. One case of pneumomediastinum was managed conservatively without discontinuing therapy.

Key Safety Considerations

Absolute Contraindications

  • Untreated pneumothorax - Must be addressed before HBOT
  • Certain patient conditions may preclude treatment (e.g., severe burns requiring specialized burn unit care) 4

Relative Precautions

  • Patients requiring mechanical ventilation need closer monitoring
  • Those with poor clinical reserve require careful selection
  • Confinement anxiety can be managed but may limit treatment adherence

Treatment Protocols That Enhance Safety

Standard protocols use 2.4-2.8 ATA pressure for defined durations 4, 2. Pre-treatment evaluations should include:

  • ENT evaluation for equalization ability
  • ECG to assess cardiac status
  • Chest X-ray to rule out pneumothorax
  • Laboratory tests as clinically indicated

Clinical Context

The safety profile must be understood in context: HBOT is used for serious conditions where the underlying disease poses significant morbidity and mortality risk. In carbon monoxide poisoning, for example, 12-68% of patients develop neurologic sequelae without treatment 6. The therapy's safety record demonstrates that treatment risks are substantially lower than disease risks in appropriate indications.

The evidence consistently shows that when administered with proper patient selection, pre-treatment evaluation, and monitoring protocols, HBOT remains among the safest therapies used in medicine today 1, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.